Picture of Pathfinder Cell Therapy logo

PFND Pathfinder Cell Therapy Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for Pathfinder Cell Therapy, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

R2010
December 31st
2011
December 31st
2012
December 31st
2013
December 31st
2014
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-1.29-11.3-2.16-1.71-1.39
Depreciation
Non-Cash Items0.4598.760.029-0.0810.002
Unusual Items
Other Non-Cash Items
Changes in Working Capital-0.010.1630.0830.1740.426
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Cash from Operating Activities-0.833-2.33-2.02-1.6-0.963
Capital Expenditures0000
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-0.324-0.83500
Acquisition of Business
Sale of Business
Other Investing Cash Flow
Cash from Investing Activities-0.324-0.83500
Financing Cash Flow Items0.307000
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities1.163.351.841.640.945
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.0020.181-0.1870.035-0.018